ATE451618T1 - Verfahren zur identifizierung von epitopen in zusammenhang mit immunogenität bei biopharmazeutika - Google Patents

Verfahren zur identifizierung von epitopen in zusammenhang mit immunogenität bei biopharmazeutika

Info

Publication number
ATE451618T1
ATE451618T1 AT06112423T AT06112423T ATE451618T1 AT E451618 T1 ATE451618 T1 AT E451618T1 AT 06112423 T AT06112423 T AT 06112423T AT 06112423 T AT06112423 T AT 06112423T AT E451618 T1 ATE451618 T1 AT E451618T1
Authority
AT
Austria
Prior art keywords
apr
peptides
immunogenicity
immunogenic
identifying
Prior art date
Application number
AT06112423T
Other languages
English (en)
Inventor
Harald Kropshofer
Anne Vogt
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE451618T1 publication Critical patent/ATE451618T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
AT06112423T 2005-04-20 2006-04-10 Verfahren zur identifizierung von epitopen in zusammenhang mit immunogenität bei biopharmazeutika ATE451618T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05103199 2005-04-20

Publications (1)

Publication Number Publication Date
ATE451618T1 true ATE451618T1 (de) 2009-12-15

Family

ID=37114190

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06112423T ATE451618T1 (de) 2005-04-20 2006-04-10 Verfahren zur identifizierung von epitopen in zusammenhang mit immunogenität bei biopharmazeutika

Country Status (8)

Country Link
US (1) US20060251664A1 (de)
JP (1) JP4275144B2 (de)
CN (1) CN1877336A (de)
AT (1) ATE451618T1 (de)
CA (1) CA2542104C (de)
DE (1) DE602006010934D1 (de)
ES (1) ES2334936T3 (de)
SG (1) SG126893A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2126584B1 (de) * 2007-03-16 2012-12-19 CovalX AG Direkte massenspektrometrische analyse von auf proteinkomplexe zielenden arzneistoffkandidaten
EP3101122B1 (de) 2009-08-24 2023-06-14 Baylor College of Medicine Erzeugung von ctl-linien mit spezifizität gegen mehrere tumorantigene oder mehrere viren
GB201121308D0 (en) 2011-12-12 2012-01-25 Cell Medica Ltd Process
PT2812431T (pt) 2012-02-09 2019-10-18 Baylor College Medicine Pepmixes para gerar ctls multivirais com larga especifidade
EP3929302A1 (de) * 2014-07-14 2021-12-29 Chugai Seiyaku Kabushiki Kaisha Verfahren zur identifizierung eines epitops auf einem protein
JP6999941B2 (ja) * 2015-09-18 2022-02-10 ベイラー カレッジ オブ メディスン 病原体からの免疫原性抗原同定および臨床的有効性との相関
BR112019020959A2 (pt) 2017-04-10 2020-05-05 Immatics Biotechnologies Gmbh peptídeos e combinações dos mesmos para uso na imunoterapia contra câncer
US11427614B2 (en) 2017-04-10 2022-08-30 Immatics Biotechnologies Gmbh Peptides and combination thereof for use in the immunotherapy against cancers
KR20210028155A (ko) * 2018-05-17 2021-03-11 이뮤놈 인코포레이티드 Ch3 도메인 에피토프 태그
JP2022155547A (ja) * 2021-03-30 2022-10-13 ミナリスメディカル株式会社 蛋白質が結合したラテックス粒子の安定化方法
WO2024138754A1 (zh) * 2022-12-30 2024-07-04 深圳吉诺因生物科技有限公司 一种hla-a*11:01限制性抗原点替换方法、获得的多肽及其应用
EP4705770A1 (de) * 2023-05-03 2026-03-11 Immunoracle Inc. Zusammensetzungen und verfahren zur analyse einer probe für antigenspezifische immunzellen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1714981A3 (de) * 2002-10-02 2006-12-20 F.Hoffmann-La Roche Ag Verfahren zur Identifizierung antigener Peptide

Also Published As

Publication number Publication date
CA2542104A1 (en) 2006-10-20
SG126893A1 (en) 2006-11-29
JP4275144B2 (ja) 2009-06-10
US20060251664A1 (en) 2006-11-09
JP2006300945A (ja) 2006-11-02
DE602006010934D1 (de) 2010-01-21
CN1877336A (zh) 2006-12-13
CA2542104C (en) 2010-12-07
ES2334936T3 (es) 2010-03-17

Similar Documents

Publication Publication Date Title
WO2004063963A3 (en) Novel proteins with altered immunogenicity
CY1120822T1 (el) Διαειδικα ειδικη επικρατεια δεσμευσης
MX337456B (es) Vacunas peptidicas para canceres que expresan antigenos asociados con tumores.
WO2007064919A3 (en) Binding polypeptides with restricted diversity sequences
UA110599C2 (uk) Пептид для імунотерапії пухлин, включаючи нейрональні пухлини та пухлини мозку
ATE521708T1 (de) Chimärische, hybrid- und tandem-polypeptide von meningococcus nmb1870
ATE451618T1 (de) Verfahren zur identifizierung von epitopen in zusammenhang mit immunogenität bei biopharmazeutika
TW200515916A (en) Chimeric antigens for breaking host tolerance to foreign antigens
MX2014005546A (es) Anticuerpos de union de albumina y fragmentos de union de los mismos.
WO2006046978A3 (en) Cationic peptide-mediated transformation
DE60139542D1 (de) Methoden zur herstellung humaner monoklonaler antikörper
PL2314623T3 (pl) Przeciwciała wiążące il-1 beta i ich fragmenty
MX361076B (es) Proteínas multifunción que comprenden complejo mayor de histocompatibilidad (cmh) de clase i multivalente unido mediante disulfuro.
CO6231038A2 (es) Proteinas de union, incluyendo anticuerpos derivados de anticuerpo y fragmentos de anticuerpo que se unen especificamente a cd154 y sus usos
WO2007146401A3 (en) Denatured collagen peptides and uses thereof
ES2531142T3 (es) Péptidos WT1 de unión a HLA de clase II, y composiciones y métodos que los comprenden
WO2011022077A3 (en) A nucleic acid cassette for producing recombinant antibodies
EP4269562A3 (de) Antigenbindende moleküle und verfahren zur verwendung davon
WO2005012531A3 (en) Antibody cdr polypeptide sequences with restricted diversity
DE602005021379D1 (de) System und verfahren zur produktion von antikörpern in der pflanzenzellkultur
MY148646A (en) Anti-psgl-1 antibodies
WO2014144911A3 (en) Hybrid immunoglobulin containing non-peptidyl linkage
NZ609916A (en) Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
WO2008010098A3 (en) Identification, optimization and use of cryptic hla-b7 epitopes for immunotherapy
WO2010009856A3 (en) Goodpasture antigen binding protein and its detection

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties